site logo
TB-500 — 10mg

TB-500 — 10mg

79.00$

  • Supplied as a lyophilized (freeze-dried) powder, 10mg total per vial
  • TB-500 is a synthetic peptide fragment commonly investigated in laboratory and biochemical research
  • Suitable for controlled research involving peptide properties, stability, and analytical characterization
  • Unreconstituted vials should be stored according to the manufacturer’s recommended conditions
  • All orders are processed within 48 hours of purchase, with delivery typically arriving in 2–5 business days
  • Intended strictly for laboratory research and professional analytical use, not for human or veterinary consumption
Category: Dosage: Brand:

Description

Wolverine (BPC-157 + TB-500) — 20 mg

Wolverine (BPC-157 + TB-500) 20 mg is a dual-peptide research formulation combining BPC-157 and TB-500 (Thymosin Beta-4 fragment, TB4-400 / 43aa) into a single lyophilized vial. This consolidated format replaces the prior two-vial presentation while preserving the same total peptide content—10 mg BPC-157 and 10 mg TB-500, for a combined 20 mg.

 

At a glance
Contents: 20 mg total (10 mg BPC-157 + 10 mg TB-500)
Form: Lyophilized powder
Purity: 99% (HPLC verified)
Intended Use: For laboratory research use only (RUO)

 

Research Overview

BPC-157 is a gastric-derived pentadecapeptide fragment that has been widely investigated in preclinical research for its role in tissue protection, angiogenic signaling, microvascular integrity, and inflammatory pathway modulation. Studies frequently examine its influence on nitric-oxide signaling, epithelial stability, and cytokine balance across a range of experimental models.

TB-500 (Thymosin Beta-4 fragment) is a synthetic peptide corresponding to the active region of the naturally occurring actin-binding protein thymosin beta-4. In research settings, TB-500 is evaluated for its involvement in cellular migration, cytoskeletal organization, and extracellular-matrix remodeling, particularly in models focused on tissue repair and regeneration dynamics.

When combined in a single formulation, BPC-157 and TB-500 present complementary mechanisms of interest: BPC-157 contributing to vascular stability and inflammatory modulation, and TB-500 supporting actin-mediated cell motility and structural reorganization. This pairing is frequently explored in preclinical studies to assess potential additive or synergistic effects on coordinated tissue-repair processes.

 

Current areas of research interest

  • Musculoskeletal and connective-tissue research, including experimental models of muscle, tendon, and ligament repair
  • Angiogenesis and microvascular studies, particularly where enhanced vascular support may influence recovery dynamics
  • Cytoskeletal and cellular-migration investigations involving fibroblast and endothelial cell behavior
  • Inflammatory-response modulation, with attention to cytokine signaling and tissue-stress pathways
  • Wound-healing and tissue-regeneration models examining extracellular-matrix organization and structural remodeling

 

Important Notice
This product is intended exclusively for laboratory and research use. Not for human or veterinary use.

Reviews

There are no reviews yet.

Be the first to review “TB-500 — 10mg”

Your email address will not be published. Required fields are marked *

Related Products

Related products